Back to Journals » Clinical Ophthalmology » Volume 15

Phase 3 Efficacy (Worse-Eye Analysis) and Long-Term Safety Evaluation of OTX-101 in Patients with Keratoconjunctivitis Sicca

Total article views   HTML views PDF downloads Totals
5,201 Dovepress* 4,609+ 687 5,296
PubMed Central* 592 199 791
Totals 5,201 886 6,087
*Since 12 January 2021

View citations on PubMed Central and Google Scholar